Trial intelligence / Profile preview

IS-001 for Ureter Visualization in Robotic Gynecological Surgery

NCT03937505Phase 2Completed

Sponsor
Intuitive Surgical
Start
May 2019
Primary completion
Jul 2021
Modality
Light/Condition-Responsive Prodrugs
Countries
1
01

Overview

Phase 2, open-label trial of filricianine in ureter injury (3 arms), sponsored by Intuitive Surgical. Primary endpoint: Evaluate fluorescent intensity of ureter by signal to background analysis at 10 minutes. Started May 2019; status: completed.

02

Drugs

filricianine
03

Conditions

ureter injury

Beyond the preview

Go deeper on NCT03937505.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03937505.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call